US 12241068
CD79-specific chimeric antigen receptor
granted A61KA61K2239/13A61K2239/31
Quick answer
US patent 12241068 (CD79-specific chimeric antigen receptor) held by AUTOLUS LIMITED expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- AUTOLUS LIMITED
- Grant date
- Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K2239/13, A61K2239/31, A61K38/00, A61K40/11